Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods

There is significant variation in the use of polymyxin B (PMB), and optimal dosing has not been defined. The purpose of this retrospective study was to evaluate the relationship between PMB dose and clinical outcomes. We included patients with bloodstream infections (BSIs) due to carbapenem-resistan...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Nelson, Brian C., Eiras, Daniel P., Gomez-Simmonds, Angela, Loo, Angela S., Satlin, Michael J., Jenkins, Stephen G., Whittier, Susan, Calfee, David P., Furuya, E. Yoko, Kubin, Christine J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2015
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604419/
https://ncbi.nlm.nih.gov/pubmed/26324272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00844-15
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk